Wikidata

(Q82709945)

English

Phase I dose-escalation and pharmacokinetic study of ispinesib, a kinesin spindle protein inhibitor, administered on days 1 and 15 of a 28-day schedule in patients with no prior treatment for advanced breast cancer

scientific article published on 01 March 2012

In more languages
default for all languages
No label defined

No description defined

Statements

title
Phase I dose-escalation and pharmacokinetic study of ispinesib, a kinesin spindle protein inhibitor, administered on days 1 and 15 of a 28-day schedule in patients with no prior treatment for advanced breast cancer (English)
1 reference
stated in
Europe PubMed Central
PubMed publication ID
22123335
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22123335%20AND%20SRC:MED&resulttype=core&format=json
retrieved
17 January 2020
author name string

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q82709945&oldid=2143404432"